case of steroid receptors, maintain them in an inactive but activation-competent conformation (Picard et al., 1990; Scherrer et al., 1992; Nathan and Lindquist, 1995) . By analogy, a slow decline in the concentration of relevant chaperones may destabilize inactive HSF1. In contrast, chaperones may become rapidly unavailable for binding HSF1 during stress, resulting in a sharp increase in the concentration of unbound HSF1. Because of the strong concentration dependence of the HSF1 trimerization reaction (Larson et al., 1988) , factor trimerization may be favored over inactivation/degradation in this situation. To avoid these predictable difficulties of in vivo approaches to identify HSF1 repressor, we developed an in vitro system that recapitulates the initial step of HSF1 activation in vivo.
Results

An In Vitro System that Reproduces the Initial
Step of HSF1 Activation A lysate system (activation lysate) was established that reproduces the earliest step in HSF1 activation in vivo, which is the conversion of inactive, nontrimeric factor to trimeric factor capable of binding HSE DNA. The criteria chosen for validation of the system were induction by heat shock, the classical inducer of Hsp expression, by denatured protein, the common proximal inducer of Hsp expression during stress, and by the Hsp90-binding compound geldanamycin. Activation lysate, prepared as described in Experi-(A-E, G, and H) EMSA of aliquots of activation lysate. RT, room mental Procedures, was exposed for 5 min to different temperature; THS, threshold heat shock; HS, heat shock; CHM, temperatures between 0ЊC and 45ЊC ( Figure 1A ). HSE cycloheximide; bac-HSF1, baculovirus-expressed HSF1; E. coli-DNA-binding activity was assessed by electrophoretic HSF1, bacterially expressed HSF1. In (C) EMSA used either a radiolabeled LexA binding site-containing probe (LexA probe) or an HSE mobility shift assay (EMSA), using a radiolabeled HSE DNA probe (all other lanes). HSE DNA, 25-fold excess of unlabeled oligonucleotide probe. Note that our gels typically re-HSE probe; HSF1 Ab, HSF1 antibody. In (G) reactions were with solved two or more distinct HSE DNA-HSF complexes.
activation lysate lacking ATP-regenerating system. HSE DNA-binding activity increased gradually with tem-(F) Native anti-HSF1 blot of activation lysate. In vivo: extract from peratures up to 41ЊC and more sharply between 41ЊC HeLa cells exposed to 42ЊC for 45 min. M, HSF1 monomers; D, and 43ЊC. The temperature at which the latter, more HSF1-Hsp/c70 heterodimers; T, HSF1 trimers. Note that different panels show results from independent assays involving independent discrete increase occurred varied somewhat between exposures of gels.
experiments (between 37ЊC and 41ЊC) . Cells sense the severity of a heat stress, which is a function of both temperature and duration of exposure (DiDomenico et al., 1982) . As in vivo, HSE DNA-binding activity of activatherefore, most readily influenced by changes in experimental parameters under threshold activation condition lysate increased with exposure time at all but the highest temperatures ( Figure 1B : exposure at 27ЊC).
tions. Therefore, activation lysate was routinely incubated at 27ЊC-29ЊC for 60 min (threshold heat shock), Thus, the in vitro system is capable of sensing heat stress, although DNA-binding activity increases with which resulted in a minor but clearly detectable increase in HSF1 DNA-binding activity. Where appropriate (inditemperature more gradually in vitro than in vivo. The latter difference may be explained, in part, by the obsercated in figures and legends), reactions incubated for 60 min at room temperature (basal level of activation) vation (see below) that HSF1 activation is a reversible process in vivo but not in vitro.
or 37ЊC (heat shock condition inducing substantial DNAbinding activity) were analyzed for comparison. Relative The heat-activated factor binds the HSE DNA probe but not an unrelated oligonucleotide probe ( Figure 1C ).
DNA-binding activities induced by the three conditions are shown in Figure 1E . Relative amounts of HSF1 triFurthermore, a 25-fold excess of unlabeled HSE DNA suppressed binding to the HSE probe (in the presence mers formed were estimated by native anti-HSF1 blot ( Figure 1F ). of a 500-fold excess of nonspecific DNA). Thus, heat treatment induced the DNA-binding activity of an HSF Since processes involving chaperones are generally ATP-dependent, activation lysate was routinely preincuthat was identified as HSF1 by HSF1 antibody supershift ( Figure 1C ). As in vivo (Zimarino and Wu, 1987) , heat bated with an ATP-regenerating system (see Experimental Procedures). That activation of HSF1 is, in fact, deactivation of HSF1 in vitro was independent of protein synthesis ( Figure 1D) . pendent on the presence of ATP was confirmed by the experiment in Figure 1G . HSF1 regulation was expected to be least stable and, al., 1995) . A similar observation was made for activation of HSF1 by denatured proteins (discussed below). These findings may reflect the temperature dependence of the HSF1 trimerization reaction. Use was made of this property of the in vitro system to further probe the notion that HSF1 activation by geldanamycin occurred as a consequence of the compound's interaction with Hsp90. Activation lysate was incubated with geldanamycin for 20 min at room temperature, which was expected to result in binding of the compound to Hsp90 and latent activation of HSF1 ( Figure 2E ). To allow trimerization to occur (here measured as DNA-binding activity), lysate was then subjected to threshold heat shock. Addition of purified Hsp90 immediately prior to the latter incubation greatly reduced the extent of HSF1 activation by geldanamycin (Hsp90 also suppressed the low-level activation occurring in the absence of geldanamycin, but see below for a more extensive analysis of this aspect). HSF1 is bound by Hsp90 and that this association prevents and its interruption promotes factor trimerization. Activation of HSF could result from either an increased Note that in the above experiments geldanamycin was rate of HSF trimerization or a reduced rate of trimer used at 50 g/ml to produce maximal effects. Activadissociation, or both. To find out which reaction was tion of HSF1 was detected at concentrations as low as affected by heat shock, we tested whether dissociation 2 g/ml. of HSF1 trimers could occur in activation lysate. Trimeric
To find out whether HSF1 could be activated by nonrecombinant HSF1 was added to activation lysate in native proteins in our in vitro system, chemically denaamounts approximately comparable to endogenous HSF1 tured bovine serum albumin (CM-BSA) and activation (estimated from EMSA of recombinant HSF1 and heatlysate (CM-extract) were prepared by denaturation in treated activation lysate). Reactions were incubated for urea and reductive carboxymethylation (Ananthan et al., up to 3 hr at room temperature ( Figure 1H ) or threshold 1986). Addition of these preparations of denatured proheat shock temperature (data not shown). EMSA retein to activation lysate (at 0.4 mg/ml) strongly stimuvealed no decrease in DNA-binding activity and, therelated HSE DNA-binding activity, whereas comparable fore, in the concentration of recombinant HSF1 trimers.
amounts of native activation lysate, BSA, or ovalbumin Similar results were obtained (data not shown) when had no effect ( Figure 3A ). This increased DNA-binding lysate was first heat-shocked and then incubated at activity was due to HSF1 ( Figures 3B and 3C ). To rule room temperature or threshold heat shock temperature.
out that the observed activation of HSF1 was caused Thus, HSF1 trimers are not efficiently disassembled by by residual urea or other chemicals, a preparation of activation lysate as used here. Activation of HSF1 ap-CM-BSA was diluted severalfold and reconcentrated pears to result exclusively from an increased rate of using a Centricon 30 Microconcentrator. The volume factor trimerization.
of the pass-through fraction was also reduced to the original volume of the protein preparation by lyophilizaActivation of HSF1 In Vitro by Geldanamycin tion. Reconcentrated protein fraction but not passand Denatured Proteins through fraction greatly stimulated DNA-binding activity Addition to activation lysate of geldanamycin but not ( Figure 3D ). It is interesting to note that the relative conof analogues macbecin II and 1,9-formyl geldanamycin centration of denatured protein at which activation of drastically enhanced HSE DNA-binding activity ( Figure  HSF1 occurs in vitro (0.5%-1.5% of total protein) is simi-2A). That this increase in DNA-binding activity reflected lar to that previously estimated to be required to trigger activation of HSF1 was documented by HSF1 antibody Hsp expression in vivo (1%-2%; Lepock et al., 1993) . supershift ( Figure 2B ) and native anti-HSF1 blot (Figure To learn whether HSF1 activation was mediated by 2C). Activation was not inhibited by strongly reducing soluble, nonnative proteins or by protein aggregates, conditions ( Figure 2D ). Thus, activation of HSF1 by gela preparation of CM-BSA was subjected to a 30 min danamycin in vitro most likely results from a reduced centrifugation at 100,000 ϫ g. About 50% of protein was activity of Hsp90 and not from oxidative protein damage.
found in the pellet fraction. Similar amounts of protein Geldanamycin activated HSF1 at threshold heat shock from the pellet and soluble fractions were incubated temperature but not at room temperature (Figures 2B with activation lysate. Only soluble, nonnative proteins and 2C), even though the compound is known to bind caused significant activation of HSF1 DNA-binding aceffectively to Hsp90 and to disrupt p23 complexes at the latter temperature (Whitesell et al., 1994; Smith et tivity ( Figure 3D ). 
Hsp90 Retains HSF1 in the Inactive, Nontrimeric State
To test whether chaperones Hsp90 and Hsp/c70 could suppress heat activation of HSF1, purified chaperones were added (at 2 mg/ml in the experiments shown) to activation lysate, and reactions were exposed to threshold heat shock. Control reactions included ovalbumin Inhibition by Hsc70 and Hsp70 was weak and variable.
(C) Native anti-HSF1 blot.
As reported previously (Abravaya et al., 1992; expense of HSF1 trimers and HSF1-Hsp/c70 complex. That no new signal corresponding to Hsp90-containing HSF1 complex appeared may be explained (see below) were removed by centrifugation. Antibody additions resulted in a slight dilution (typically less than 2-fold) of by the instability of this complex in buffers containing salt at moderate to high concentrations (such as the reactions. Because the HSF1 trimerization reaction is highly concentration-dependent, Hsp90 and control anbuffers used in native electrophoresis).
If Hsp90 plays a significant, nonredundant role in retibody-treated lysates were reconcentrated to the original protein concentration by lyophilization. Incubation taining HSF1 in the inactive state, immunodepletion of Hsp90 from activation lysate would be expected to rewith Hsp90 antibody reduced the concentration of Hsp90 by about 80% (Figures 4D and 4F ). Similar alisult in factor activation. Results from two immunodepletion experiments are presented in Figures 4D-4G . These quots of Hsp90 and control antibody-treated lysates were exposed to threshold heat shock and then assayed experiments were selected from nine independent experiments to show maximal and minimal activating efby EMSA ( Figures 4E and 4G ). On average, Hsp90 antibody-treated lysate exhibited about 10-fold higher HSE fects observed. Parallel reactions were incubated on ice for 4 hr with immobilized Hsp90 antibody AC88 and DNA-binding activity than control antibody-treated lysate. Induced DNA-binding activity in Hsp90 antibody-treated isotype-matched control antibody Cd11c, respectively. Note that antibody AC88 is known to prefer free over lysate was supershifted quantitatively by anti-HSF1 antibody ( Figure 4G ). Deregulation of HSF1 DNA-binding complexed Hsp90. At the end of reactions, antibodies activity could be prevented by addition of purified Hsp90 (at 1 mg/ml in Figure 4E and 2 mg/ml in Figure 4G ) to Hsp90 antibody-treated lysate prior to exposure to threshold heat shock. We conclude from these results that Hsp90 plays a nonredundant role in keeping HSF1 in the inactive, nontrimeric state, that is, in repressing HSF1 activation. The results also imply that the interaction between inactive HSF1 and Hsp90 is dynamic. In additional experiments (data not shown) in which Hsp90 and control antibody-treated lysates were mixed at different ratios prior to incubation, we observed that a 40%-50% reduction of the level of Hsp90 was sufficient to cause detectable activation of HSF1.
HSF1 Is Not Activated upon Depletion of Constituents of Hsp90-Containing Multichaperone Complexes Other than Hsp90
In light of the dramatic activating effect of Hsp90 depletion, it appeared unlikely that Hsp/c70 could function as an independent HSF1 repressor of similar importance as Hsp90. However, Hsp/c70 is also a constituent of Hop complex. This and other Hsp90-containing multichaperone complexes exist in dynamic equilibria with their respective constituents. If Hsp90 repressed HSF1 activation only in the context of Hop complex, depletion of any essential constituent of this complex (i.e., Hsp90, Hop, and Hsp/c70) should result in dissociation of the complex and in deregulation of HSF1 activity. To test c70-depleted and mock-depleted lysates exposed to by Hsp70 (2 mg/ml) and Hsp90 (2 mg/ml) added prior to incubation threshold heat shock revealed that removal of Hsp/c70 under threshold heat shock conditions. Rabbit serum served as did not deregulate HSF1 activity ( Figure 4I ). Exposure control for Hsp40, CyP40, and HSF1 antibodies, and mouse monoclonal antibody Cd11c for Hop, Hip, and p23 antibodies.
to higher temperature (heat shock condition) induced similarly elevated levels of HSF1 DNA-binding activity in the two lysates ( Figure 4I ). Thus, Hsp/c70-and, by lysate. Steroid receptor complexes, which are similarly extension, Hsp90-containing Hop complexes appear dynamic, were previously found to be reasonably stable not to be independent repressors of HSF1 activation.
in extract prepared in buffer containing little salt and Similar immunodepletion experiments were also carried lacking detergent (Sanchez et al., 1990) . Using similar out using antibodies against Hop and Hop complexconditions, we recently succeeded in coimmunoprecipiassociated protein Hip. Again, even though the concentating HSF1 from extract of unstressed cells using an trations of Hop and Hip could be reduced to low levels Hsp90 antibody (data not shown). To obtain evidence ( Figures 5B and 5D ), no significant activation of HSF1 that the mechanism of HSF1 repression delineated by occurred ( Figures 5A and 5D ). Immunodepletion (Fig- the above in vitro experiments can operate in the cell, we ures 5B and 5C) of two constituents of p23 complexes, wished to demonstrate that Hsp90-containing (inactive) p23 and CyP40, similarly failed to activate HSF1 (Figures HSF1 complex is formed in the cell. In the experiment 5A and 5C). Thus, neither Hop nor p23 complexes, nor shown in Figure 6A , unstressed HeLa cell cultures were their individual constituents (other than Hsp90), play exposed to the chemical cross-linker dithiobis(succininonredundant roles in repressing HSF1 activity. Analomidyl propionate) for 5 min. As indicated by trypan blue gous observations were also made for Hsp40 (Figures staining, the integrity of cells was preserved under the 5A and 5B).
conditions used. Cross-linking reagent was rapidly removed, cells were harvested, and extract was prepared. Hsp90-containing complexes were pulled down under Hsp90-Containing HSF1 Complex Forms in the Cell and Dissociates Rapidly during Stress stringent conditions using Hsp90 antibody 9D2 (or, in experiments not shown, Hsp90 antibody H9010 proAs discussed before, the interaction between HSF1 and Hsp90 appears to be dynamic. In agreement with this vided by David Toft). After reversal of cross-linking, immunoprecipitated proteins were analyzed by anti-HSF1 notion, we were consistently unable to immunoprecipitate an Hsp90-containing HSF1 complex from activation and anti-Hsp90 blot. Results showed that HSF1 was activation of HSF1 by different benzoquinone ansamycins was compared in vivo and in vitro. Geldanamycin but not macbecin II and 1,9-formyl geldanamycin was found to activate HSF1 in vitro under strongly reducing conditions (Figures 2A and 2D ). The experiment in Figure  6C revealed that the relative potencies (for HSF1 activation) of the three compounds are similar in vivo and in vitro, suggesting that they act in vivo as they do in vitro.
To demonstrate that geldanamycin can activate HSF1 in vivo under conditions in which oxidation of the intracellular environment cannot occur, cells were preincubated for 2 hr in the presence of 1 mM DTT (conditions adapted from Huang et al., 1994) . At this relatively high concentration of reducing agent, protein synthesis is severely inhibited (data not shown). Inhibition of protein synthesis is known to substantially raise the threshold for stress activation of HSF1, presumably because of an increased availability of chaperones for processes in Figure 6D , preincubation with DTT and, reproducing Our evidence for a role of Hsp90 in the repression of HSF1 activation is threefold. First, immunodepletion of present in immunoprecipitated complexes. Control imHsp90 results in drastic enhancement of HSF1 activity munoprecipitations in which the Hsp90 antibody was upon incubation of depleted lysate under threshold actisubstituted by an isotype-matched control antibody, or vation conditions. Purified Hsp90 suppresses this deomitted, failed to recover HSF1. Furthermore, HSF1 regulation of HSF1 activity ( Figures 4D-4G ). While these could not be coimmunoprecipitated from extract of naresults were obtained from experiments that monitored ive cells. These data indicate that Hsp90-containing deregulation of HSF1 activity at 27ЊC-29ЊC (threshold HSF1 complex is formed in the cell. That HSF1 was heat shock), analogous immunodepletion experiments quantitatively present in the inactive, nontrimeric form confirmed that Hsp90 can also function as HSF1 represin the unstressed cells ( Figure 6B ) strongly suggests sor at 37ЊC, the normal temperature of the human cell that the complex includes inactive HSF1. To find out (data not shown). The latter experiments were carried whether HSF1 is released from the complex during out with 2-fold diluted activation lysate. This dilution stress, relative amounts of complex were compared in reduced the rate of HSF1 activation at 37ЊC to about unstressed cells and cells exposed to a 5 min 45ЊC heat that typically observed at 27ЊC-29ЊC. Second, addition shock ( Figure 6A ). The complex was virtually absent in of Hsp90 to the in vitro system suppresses activation the heat-treated cells, and essentially all HSF1 was in of HSF1 by threshold heat shock ( Figures 4A and 4B ), the trimeric form ( Figure 6B ). Thus, Hsp90-containing geldanamycin ( Figure 2E ), and chemically denatured HSF1 complex dissociates during stress, and complex BSA (not shown). Finally, Hsp90-specific compound dissociation and HSF1 trimerization are closely corregeldanamycin activates HSF1 in vitro as well as in lated events.
vivo under strongly reducing conditions in which the compound cannot cause protein oxidation (Figures 2D HSF1 Activation by Benzoquinone and 6D).
Ansamycins In Vivo
Several independent lines of experimentation support Susceptibility of a process to benzoquinone ansamycins our conclusion that Hsp90 forms a complex with inactive such as geldanamycin is generally accepted as strong HSF1 and is released from this complex during stress. evidence for an involvement of Hsp90 in the process.
First, assays of protease sensitivity of HSF1 in activation However, since the compounds can also act as redox lysate suggested that inactive HSF1 is bound by a factor cyclers and may cause oxidative protein unfolding, they that can be released by geldanamycin ( Figure 2F ). Since may not reliably indicate the participation of Hsp90 in geldanamycin is a specific Hsp90-binding compound, a mechanism such as the heat shock response that is this factor is likely to be identical with Hsp90 or Hsp90-containing chaperone complex(es). Second, a typically triggered by nonnative protein. To address this concern, be activatable when associated with a multichaperone complex (Hutchison et al., 1995; Smith et al., 1995) . Future work will need to examine whether Hop and p23 complexes can interchangeably function as HSF1 repressors. Alternatively, Hsp90 may repress HSF1 activation in the context of a yet undiscovered multichaperone complex.
Two observations appear to be inconsistent with a role of Hsp70 as a major HSF1 repressor. First, virtually quantitative depletion of both Hsp70 and Hsc70 from activation lysate fails to cause deregulation of HSF1 activity. Second, reduction of the level of Hsp90 massively activates HSF1. Thus, there appears to be little opportunity for Hsp/c70 to function as an independent HSF1 repressor of consequence. Still, a small fraction of inactive HSF1 is found in a binary complex with Hsp/ c70 in cell extracts (Rabindran et al., 1994; Baler et al., 1996 ; see also Nunes and Calderwood, 1995) . The complex has been portrayed as an ordered process Differences in grayscale indicate differences in relative concentrainitiated by binding of Hsp70 to receptor (Smith, 1993;  tions of proteins/complexes. Smith et al., 1995) . By analogy, we suggest that formation of HSF1-Hsp/c70 complex may be a required initial minor fraction of inactive HSF1 is associated with Hsp/ step leading to the formation of an Hsp90-containing c70 in activation lysate. Addition of Hsp90 displaces HSF1 complex, from which HSF1 can be activated. ConHsp/c70 from HSF1 ( Figure 4C ). This is likely to reflect ceivably, HSF1 may be prevented from trimerizing as the formation of an Hsp90-containing HSF1 complex soon as it associates with Hsp/c70. To test this notion at the expense of HSF1-Hsp/c70 complex. Recently, in a situation in which mature HSF1 complex does not stabilizing conditions were identified under which Hsp90-form efficiently and a large fraction of inactive HSF1 containing HSF1 complex can be immunoprecipitated should be available for binding Hsp/c70, an experiment (data not shown). Finally, Hsp90-containing HSF1 comwas performed using Hsp90-depleted lysate ( Figure 5E ). plex can be stabilized in the cell by cross-linking. Upon
Addition of Hsp70 to this lysate prevented activation, heat treatment of cells, the complex dissociates rapidly, albeit less efficiently than back addition of Hsp90. Thus, and HSF1 trimers form ( Figures 6A and 6B) .
it does appear that HSF1 associated with Hsp/c70 is Hsp90-containing HSF1 complex is dynamic. As disunavailable for trimerization. This result may provide for cussed before, the complex is normally unstable and an explanation for the observation that overexpression can only be isolated under conditions known to stabilize of Hsp70 renders cells somewhat refractory to heat actiHsp90 interactions. Furthermore, that immunodepletion vation of HSF1 DNA-binding or transcriptional activity of Hsp90 results in HSF1 activation implies that HSF1- (Mosser et al., 1993; Baler et al., 1996 ; but see also bound Hsp90 is in rapid equilibrium with unbound Rabindran et al., 1994) as well as for analogous findings Hsp90. Our findings are summarized in the following made by Xiao and DeFranco (1997) . Note, however, that model of regulation of HSF1 activation (Figure 7) . In the the latter findings may be explained differently. unstressed cell, most HSF1 molecules are present in an Hsp90-containing complex(es) (which may further to Hsp90 or Hsp90 multichaperone complex(es). As a cose]) supplemented with 10% fetal calf serum and antibiotics (penicillin and streptomycin, both at 100 IU/ml) at 37ЊC and under 5% result, the cycle of HSF1 complex assembly and dissoci-phosphokinase. Lysate containing ATP-regenerating system is remonoclonal Hsp90 antibody 9D2 (Lai et al., 1984) and isotypematched control monoclonal antibody Mac 1 (Boehringer Mannferred to herein as activation lysate. Typically, reactions containing 9 l of activation lysate were preincubated for 20 min at room temheim) were used for immunoprecipitation, and the rabbit anti-HSF1 antibody described by Rabindran et al. (1991) for Western blot deperature. After additions (1-2 l), reactions were incubated in a waterbath for 1 hr at 27ЊC-29ЊC (threshold activation/heat shock tection of HSF1. Both the HSF1 antibody and 9D2 were obtained from StressGen Biotechnologies Corp. temperature). Subsequent to incubation, reactions were cooled in ice water and kept on ice. In most experiments, aliquots of 1 l were tested by EMSA or native anti-HSF1 blot.
Protease Sensitivity Assay Activation lysate was preincubated at room temperature for 15-20 min with or without geldanamycin. One microliter of a solution of Preparation of Hsps for Use in In Vitro Activation Assays chymotrypsin (62.5 g/ml) in reaction buffer was then added to 10 Sephadex G25 spin columns (Boehringer Mannheim Corp., Indial of activation lysate, which was then incubated further at room napolis, IN) were blocked and equilibrated in 0.4ϫ reaction buffer temperature. Aliquots of 1-2 l were removed at intervals into 9 containing 2 mg/ml bovine serum albumin (BSA). Purified bovine l of SDS-PAGE sample buffer and immediately boiled for 5 min. Hsp90, bovine Hsc70, and recombinant human Hsp70 (obtained in Samples were analyzed by anti-HSF1 Western blot. lyophilized form from StressGen Biotechnologies Corp., Victoria, BC) were reconstituted in water to concentrations of 2 mg/ml. Aliquots of 50 l were added to preequilibrated spin columns, which Recombinant HSF1 For preparation of bacterially expressed HSF1, a full-length human were centrifuged at 1,000 ϫ g for 2 min at room temperature. Eluates (about 50 l) were concentrated by lyophilization to 5 l, resulting HSF1-coding sequence (Baler et al., 1993) was subcloned into vector pGEX-2T (Pharmacia, Piscataway, NJ). Glutathione-HSF1 fusion in Hsp stock solutions with concentrations close to 20 mg/ml in 4ϫ reaction buffer. These stocks were diluted 10-to 20-fold into protein was expressed in E. coli BL21 and purified on glutathione beads (Glutathione Sepharose 4B, from Pharmacia). Bound fusion activation reactions, which increased the buffer concentration in reactions to maximally 1.4ϫ reaction buffer. Preliminary experiprotein was treated with bovine thrombin (Pharmacia) to release full-length HSF1. For preparation of baculovirus-expressed HSF1, ments demonstrated that activatability of HSF1 was maintained at buffer concentrations as high as 2.0ϫ.
a DNA sequence encoding amino-terminally FLAG-tagged HSF1 was transferred to baculovirus shuttle vector VL1393 (Pharmingen, San Diego, CA), and recombinant baculovirus Immunodepletion Experiments was isolated and stock prepared by a standard procedure (O'Reilly For Hsp90 immunodepletion, protein A agarose beads (50 l packed et al., 1992). FLAG-tagged HSF1 was expressed in insect SF9 cells, beads) were preincubated with reaction buffer containing 2 mg/ml purified on anti-FLAG M2 antibody affinity matrix (IBI, New Haven, of BSA. Half of the beads were then reacted for 4 hr at 4ЊC with 200 CT), and released by FLAG peptide (IBI). FLAG peptide was subsel of reaction buffer containing 20 g of monoclonal Hsp90 antibody quently removed. Amounts and purity of HSF1 preparations were AC88 , and the other half with a similar amount estimated by SDS-PAGE and Coomassie blue staining. of control antibody, which was a monoclonal lymphocyte function antigen 1 antibody (Cd11c). In vitro activation lysate (50 l) was Electrophoretic Mobility Shift Assays incubated with the loaded antibody beads for 4 hr at 4ЊC. After
Reactions were conducted essentially as described in Zuo et al., removal of antibody beads, lysate was concentrated about 2-fold 1994. For HSE and LexA oligonucleotide probes see Baler et al., by lyophilization (to restore original protein concentration). Protein 1993, and Zuo et al., 1994 , respectively. Samples tested were either concentration was verified by Protein Assay, and adjustment was activation lysate or, in the case of in vivo experiments, extract premade as necessary by addition of a small volume of water. The pared by repeated freezing and thawing of cells in high-salt buffer same protocol was used for immunodepletion of other chaperones essentially as described in Baler et al., 1993 . For HSF1 supershift and associating proteins. When rabbit sera were used (CyP40, experiments, 0.5 l of anti-HSF1 serum (Baler et al., 1993) or preimHsp40, preimmune), 25 l protein A (packed) beads were loaded mune rabbit serum were added to 10 l binding reactions at the with 5 l of serum. Antibodies: F5 (Hop; , JJ5 (p23; end of incubations. Reactions were analyzed by electrophoresis on Johnson et al., 1994) , BB70 (Hsp/c70; Smith et al., 1993), 2G6 (Hip;  4.5% PAGE gels in TGE buffer (40 mM Tris-base, 400 mM glycine, Prapapanich et al., 1996) , Hsp40 antibody (polyclonal; Hattori et al., 2 mM EDTA). Gels were dried and exposed for autoradiography. 1993), and CyP40 antibody (polyclonal; PA3-022). AC88 and BB70 were from StressGen Biotechnologies Corp., Cd11c from Boehringer Mannheim Corp., PA3-022 from Affinity Bioreagents, Inc., Native Anti-HSF1 Blots and Western Blots For native PAGE, typically 1 l of activation lysate or, in the case Golden, CO, and actin antibody from Amersham Corp., Arlington Heights, IL.
of in vivo experiments, cell extract prepared as described above was added to 10 l of EMSA buffer, and the solution was applied to a limiting pore size gel in TGE buffer. Electrophoresis, blotting, Cross-linking In Situ and immunodetection were performed as described previously Cultures of human HeLa cells were grown as described before. Heat (Baler et al., 1993; Zuo et al., 1994) . Immunoblots of SDS-PAGE gels treatment was by incubation in a 45ЊC water bath. Cultures (in 150 were prepared analogously. For all HSF1 blots, except those in mm dishes) were washed twice with phosphate-buffered saline Figure 6 , and antibody supershift assays the polyclonal HSF1 anti-(PBS) and then incubated for 5 min at room temperature with PBS body characterized by Baler et al. (1993) was used. In addition to (8 ml) containing 2 mM dithiobis(succinimidyl propionate) in DMSO HSF1 (75-80 kDa), this antibody recognizes two other HeLa proteins or DMSO only. Cross-linker was quenched by addition of 10 mM with subunit MW of 110 kDa and 57 kDa, respectively, in Western glycine. Cells were washed once with PBS and then harvested and blots. Note that the latter proteins are not seen by the antibody in lysed by incubation for 15 min on ice with RIPA buffer (50 mM Tristheir native conformations (Baler et al., 1993) . HCl [pH 8.0], 0.15 M NaCl, 1% NP-40, 0.1% SDS, 0.5% deoxycholic acid, and protease inhibitors ["Complete"; Boehringer Mannheim]). Acknowledgments After centrifugation for 10 min at 16,000 ϫ g, protein concentrations of lysates were determined by Dc Protein Assay (Bio-Rad LaboraWe are grateful to Bill Welch, David Toft, and StressGen Biotechnoltories) and equalized. Immunoprecipitations were performed with ogies Corporation for antibodies and purified Hsps, and Luke 500-600 l of lysates (2-4 mg/ml protein). Lysates were first incuWhitesell for geldanamycin analogs. We thank David Toft for discusbated in the cold with 30 g of monoclonal antibody and then with sions, Alfred Goldberg, and William Welch for critically reading this 50 l of a slurry of protein G-agarose conjugate. Immunoprecipitates manuscript, and Frank Boellmann for help with the art work. This were collected by centrifugation and washed extensively with RIPA study was supported by the National Institutes of Health (GM31125). buffer. Washed immunoprecipitates were taken up in SDS-PAGE sample buffer (containing reducing agent) and boiled for 5 min. The latter step reverses cross-linking. In the experiments shown, Received April 20, 1998; revised July 13, 1998.
